ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 23.3 TWD Market Closed
Market Cap: 18.4B TWD
Have any thoughts about
ScinoPharm Taiwan Ltd?
Write Note

Relative Value

The Relative Value of one ScinoPharm Taiwan Ltd stock under the Base Case scenario is 21.24 TWD. Compared to the current market price of 23.3 TWD, ScinoPharm Taiwan Ltd is Overvalued by 9%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
21.24 TWD
Overvaluation 9%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
22
Median 3Y
6.5
Median 5Y
6.6
Industry
2.6
Forward
6.1
vs History
98
vs Industry
7
Median 3Y
70.6
Median 5Y
72.7
Industry
23
Forward
87.9
vs History
47
vs Industry
8
Median 3Y
33.9
Median 5Y
29.3
Industry
17.8
vs History
31
vs Industry
1
Median 3Y
77.2
Median 5Y
39.1
Industry
25.4
vs History
84
vs Industry
39
Median 3Y
1.9
Median 5Y
2
Industry
2.2
vs History
98
vs Industry
24
Median 3Y
5.3
Median 5Y
5.4
Industry
2.8
Forward
4.9
vs History
93
vs Industry
14
Median 3Y
13.4
Median 5Y
13.6
Industry
5.4
vs History
98
vs Industry
19
Median 3Y
21.7
Median 5Y
22.1
Industry
13.7
Forward
614.3
vs History
98
vs Industry
9
Median 3Y
51
Median 5Y
50.2
Industry
17.2
Forward
70.3
vs History
47
vs Industry
10
Median 3Y
27.5
Median 5Y
24.9
Industry
16.5
vs History
28
vs Industry
3
Median 3Y
42.9
Median 5Y
32.1
Industry
19.3
vs History
88
vs Industry
34
Median 3Y
2.2
Median 5Y
2.2
Industry
2

Multiples Across Competitors

Competitors Multiples
ScinoPharm Taiwan Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TW
ScinoPharm Taiwan Ltd
TWSE:1789
18.4B TWD 5.4 45.7 16.3 33.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
771.1B USD 18.9 92.1 49.5 55.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35.3 24.5 28
US
Johnson & Johnson
NYSE:JNJ
368.9B USD 4.2 25.1 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
249.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.8B CHF 3.6 18.2 10.3 12.2
CH
Novartis AG
SIX:NOVN
179.9B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
157.3B GBP 4.1 31 169.2 253.5
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
TW
ScinoPharm Taiwan Ltd
TWSE:1789
Average P/E: 35.1
45.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.1
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35.3
86%
US
Johnson & Johnson
NYSE:JNJ
25.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top